Some PCOS patients report pregnancy after starting semaglutide, having previously struggled with infertility
To date, tens of thousands of research participants have received GLP-1RAs in RCTs investigating efficacy for improving glycemic control, body weight, and cardiovascular outcomes
It happens because the body cannot make enough healthy red blood cells to carry oxygen to your tissues, so your cells struggle to function efficiently
It works by mimicking the action of the naturally occurring hormone GLP-1, which stimulates insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite
Saxenda was the first to be approved in 2014, followed by Wegovy in 2020 and Zepbound in 2023
2000 Jul;38(7):625-34 No Abstract [3] Kidd PM